RS59653B1 - Biološka barijera sa simetikonom za upotrebu u lečenju nazo-faringo-tubalnih infekcija - Google Patents

Biološka barijera sa simetikonom za upotrebu u lečenju nazo-faringo-tubalnih infekcija

Info

Publication number
RS59653B1
RS59653B1 RS20191590A RSP20191590A RS59653B1 RS 59653 B1 RS59653 B1 RS 59653B1 RS 20191590 A RS20191590 A RS 20191590A RS P20191590 A RSP20191590 A RS P20191590A RS 59653 B1 RS59653 B1 RS 59653B1
Authority
RS
Serbia
Prior art keywords
simethicone
composition according
treatment
cfu
peg
Prior art date
Application number
RS20191590A
Other languages
English (en)
Serbian (sr)
Inventor
Luigi Mercuri
Licia Tiberi
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Publication of RS59653B1 publication Critical patent/RS59653B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
RS20191590A 2014-10-28 2015-10-23 Biološka barijera sa simetikonom za upotrebu u lečenju nazo-faringo-tubalnih infekcija RS59653B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM20140610 2014-10-28
ITUB20151275 2015-06-10
EP15191268.0A EP3015109B1 (en) 2014-10-28 2015-10-23 Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections

Publications (1)

Publication Number Publication Date
RS59653B1 true RS59653B1 (sr) 2020-01-31

Family

ID=54330698

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20191590A RS59653B1 (sr) 2014-10-28 2015-10-23 Biološka barijera sa simetikonom za upotrebu u lečenju nazo-faringo-tubalnih infekcija

Country Status (10)

Country Link
EP (1) EP3015109B1 (pl)
DK (1) DK3015109T3 (pl)
ES (1) ES2761613T3 (pl)
HU (1) HUE047234T2 (pl)
LT (1) LT3015109T (pl)
MA (1) MA39805A (pl)
PL (1) PL3015109T3 (pl)
PT (1) PT3015109T (pl)
RS (1) RS59653B1 (pl)
SM (1) SMT201900727T1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108114262B (zh) * 2018-02-09 2021-08-27 福建中医药大学 一种治疗腺样体肥大的中药穴位外用制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
WO2004072272A1 (en) 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US20110256179A1 (en) * 2008-11-17 2011-10-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
EP2555785B8 (en) 2010-04-07 2016-07-13 D.M.G. Italia Srl Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
US8343464B2 (en) 2010-04-30 2013-01-01 Burns Phillip E Composition and method for treating eustachian tube dysfunction

Also Published As

Publication number Publication date
EP3015109A1 (en) 2016-05-04
SMT201900727T1 (it) 2020-01-14
LT3015109T (lt) 2019-12-27
PT3015109T (pt) 2019-12-18
HUE047234T2 (hu) 2020-04-28
DK3015109T3 (da) 2019-12-16
MA39805A (fr) 2016-05-04
ES2761613T3 (es) 2020-05-20
EP3015109B1 (en) 2019-09-18
PL3015109T3 (pl) 2020-04-30

Similar Documents

Publication Publication Date Title
TWI402075B (zh) 長雙歧桿菌ｎｃｃ２７０５（ｃｎｃｍ ｉ－２６１８）及免疫病症
CN104168905B (zh) 使用乳双歧杆菌bl-04治疗呼吸道疾病
IL295525A (en) A preparation containing lactoferrin and probiotic bacterial strains for oral use with antiviral action
Tonguc-Altin et al. Development of novel formulations containing Lysozyme and Lactoferrin and evaluation of antibacterial effects on Mutans Streptococci and Lactobacilli
RS62644B1 (sr) Terapija bakteriofagima
Dicks et al. Medical and personal care applications of bacteriocins produced by lactic acid bacteria
CN110234322A (zh) 用于治疗链球菌感染以治疗牛皮癣的抗生素化合物的施用
CN107405370A (zh) 含有Lactococcus chungangensis作为有效成分的用于预防或治疗炎性疾病的药物组合物
JP2024512218A (ja) 組成物およびその使用
JP5544234B2 (ja) 歯周病菌生育抑制用組成物
WO2018188123A1 (zh) 一种微生物黏附率调节剂及其应用
JP2024520793A (ja) ウイルス性呼吸器感染症の予防的処置方法または補助的処置方法における使用のためのプロバイオティック細菌株
John et al. Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?
RS59653B1 (sr) Biološka barijera sa simetikonom za upotrebu u lečenju nazo-faringo-tubalnih infekcija
US20230277483A1 (en) Compositions and methods to treat inflammation
TWI496578B (zh) 流感病毒感染症的治療劑
JP7654014B2 (ja) 細菌株を含む組成物、ならびに眼の疾患および病変の処置のための同組成物の使用
RU2262350C2 (ru) Вакцина для иммунопрофилактики и иммунотерапии заболеваний человека и животных, вызванных патогенными и условно-патогенными грамотрицательными микроорганизмами кишечной группы и их экзотоксинами, и способ ее получения (варианты), иммуноглобулиновый препарат (варианты) и способ его получения, иммунобиологический препарат, поликомпонентная вакцина
Alneamah et al. Probiotics: Benefits against the risks
ITFI20130131A1 (it) Composizione farmaceutica per la prevenzione ed il trattamento di patologie ad eziologia infettiva
Reid Extra intestinal effects of prebiotics and probiotics
EP3015110A1 (en) Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
Ramond et al. Original Research Article Hydroxypropyl methylcellulose-based films embedded with garlic oil-loaded chitosan microparticles as a potential oral mucosal drug delivery system
WO2025033535A1 (ja) タイトジャンクション保護用組成物
Kroeker et al. Treatment of Ulcerative Colitis